Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience

Randall C. Starling; Michael Pham; Hannah Valantine; Leslie Miller; Howard Eisen; E. Rene Rodriguez; David O. Taylor; Mohamad H. Yamani; Jon Kobashigawa; Kenneth McCurry; Charles Marboe; Mandeep R. Mehra; Andreas Zuckerman; Mario C. Deng

doi:10.1016/j.healun.2006.10.002

Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience

Randall C. Starling, Michael Pham, Hannah Valantine, Leslie Miller, Howard Eisen, E. Rene Rodriguez, David O. Taylor, Mohamad H. Yamani, Jon Kobashigawa, Kenneth McCurry, Charles Marboe, Mandeep R. Mehra, Andreas Zuckerman, Mario C. Deng

Research output: Contribution to journal › Editorial › peer-review

92 Scopus citations

Original language	English (US)
Pages (from-to)	1389-1395
Number of pages	7
Journal	Journal of Heart and Lung Transplantation
Volume	25
Issue number	12
DOIs	https://doi.org/10.1016/j.healun.2006.10.002
State	Published - Dec 2006
Externally published	Yes

Bibliographical note

Funding Information:
Supported by XDx, Inc. (M.C.D., R.C.S., J.K., M.R.M., H.E.), World Heart, Inc. (M.C.D., R.C.S.), Novartis (R.C.S., H.E.), Thoratec (R.C.S., H.E.), Wyeth (H.E.), Fujisawa (H.E.), Medtronic (H.E.), Glaxo-SmithKline (H.E.), Mensanna Research (H.E.), Acorn Cardiovascular (R.C.S., H.E.), Roche Diagnostics (H.E.), National Institutes of Health (M.C.D., H.E.) and the American Heart Association (M.C.D., H.E.).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.healun.2006.10.002

OpenUrl availability

Full text

Cite this

Starling, R. C., Pham, M., Valantine, H., Miller, L., Eisen, H., Rodriguez, E. R., Taylor, D. O., Yamani, M. H., Kobashigawa, J., McCurry, K., Marboe, C., Mehra, M. R., Zuckerman, A., & Deng, M. C. (2006). Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience. Journal of Heart and Lung Transplantation, 25(12), 1389-1395. https://doi.org/10.1016/j.healun.2006.10.002

Starling, RC, Pham, M, Valantine, H, Miller, L, Eisen, H, Rodriguez, ER, Taylor, DO, Yamani, MH, Kobashigawa, J, McCurry, K, Marboe, C, Mehra, MR, Zuckerman, A & Deng, MC 2006, 'Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience', Journal of Heart and Lung Transplantation, vol. 25, no. 12, pp. 1389-1395. https://doi.org/10.1016/j.healun.2006.10.002

@article{93ad3202387c4c41b2d03068648578e7,

title = "Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience",

author = "Starling, {Randall C.} and Michael Pham and Hannah Valantine and Leslie Miller and Howard Eisen and Rodriguez, {E. Rene} and Taylor, {David O.} and Yamani, {Mohamad H.} and Jon Kobashigawa and Kenneth McCurry and Charles Marboe and Mehra, {Mandeep R.} and Andreas Zuckerman and Deng, {Mario C.}",

note = "Funding Information: Supported by XDx, Inc. (M.C.D., R.C.S., J.K., M.R.M., H.E.), World Heart, Inc. (M.C.D., R.C.S.), Novartis (R.C.S., H.E.), Thoratec (R.C.S., H.E.), Wyeth (H.E.), Fujisawa (H.E.), Medtronic (H.E.), Glaxo-SmithKline (H.E.), Mensanna Research (H.E.), Acorn Cardiovascular (R.C.S., H.E.), Roche Diagnostics (H.E.), National Institutes of Health (M.C.D., H.E.) and the American Heart Association (M.C.D., H.E.). ",

year = "2006",

month = dec,

doi = "10.1016/j.healun.2006.10.002",

language = "English (US)",

volume = "25",

pages = "1389--1395",

journal = "Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier USA",

number = "12",

}

TY - JOUR

T1 - Molecular Testing in the Management of Cardiac Transplant Recipients

T2 - Initial Clinical Experience

AU - Starling, Randall C.

AU - Pham, Michael

AU - Valantine, Hannah

AU - Miller, Leslie

AU - Eisen, Howard

AU - Rodriguez, E. Rene

AU - Taylor, David O.

AU - Yamani, Mohamad H.

AU - Kobashigawa, Jon

AU - McCurry, Kenneth

AU - Marboe, Charles

AU - Mehra, Mandeep R.

AU - Zuckerman, Andreas

AU - Deng, Mario C.

N1 - Funding Information: Supported by XDx, Inc. (M.C.D., R.C.S., J.K., M.R.M., H.E.), World Heart, Inc. (M.C.D., R.C.S.), Novartis (R.C.S., H.E.), Thoratec (R.C.S., H.E.), Wyeth (H.E.), Fujisawa (H.E.), Medtronic (H.E.), Glaxo-SmithKline (H.E.), Mensanna Research (H.E.), Acorn Cardiovascular (R.C.S., H.E.), Roche Diagnostics (H.E.), National Institutes of Health (M.C.D., H.E.) and the American Heart Association (M.C.D., H.E.).

PY - 2006/12

Y1 - 2006/12

UR - http://www.scopus.com/inward/record.url?scp=33845429123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845429123&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2006.10.002

DO - 10.1016/j.healun.2006.10.002

M3 - Editorial

C2 - 17178330

AN - SCOPUS:33845429123

SN - 1053-2498

VL - 25

SP - 1389

EP - 1395

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

IS - 12

ER -

Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this